BASF's Q3 Growth Was Mostly Pricing, and Its Interest in Evonik Is Still Only a Letter

BASF SE reported third-quarter 2026 sales of €16.4 billion on October 28, 2026, up 14% from the same quarter a year earlier. Its EBITDA before special items came to €1.6 billion, up 15%. The company's news release carried the headline "Strength across all core businesses drives BASF Group's considerable growth in EBITDA before special items."
BASF attributed the 14% sales increase to 12% higher prices and 2% higher volumes. Volume means the quantity actually sold, so price did most of the work.
That split matters more for a chemicals group than it would for most sellers. Price-led growth shows what customers are paying, but it says less about demand, and it can reverse quickly if input costs fall or competitors cut prices. Two percent volume growth is positive but modest. It is the figure I would want to see strengthen before calling the top line a demand story.
EBITDA, or earnings before interest, taxes, depreciation and amortization, is a proxy for operating cash generation. It strips out financing costs, tax and the accounting charges for aging assets. "Before special items" means BASF excludes what it classes as one-off items. EBITDA rising 15% against sales rising 14% implies a slight widening of margin. On the reported figures, €1.6 billion on €16.4 billion works out to roughly 9.8% of sales.
EBITDA is measured before tax and before capital spending, so it flatters capital-intensive businesses compared with free cash flow.
Separately, on October 22, 2026, BASF SE sent a letter to Evonik Industries AG expressing interest in making a voluntary public takeover offer for the Essen-based specialty chemicals group. A voluntary public takeover offer is a bid the bidder chooses to put directly to the target's shareholders. The letter expresses interest. It is not, on its own, a bid.
Eight days later, on October 30, 2026, Evonik's Executive Board issued an ad-hoc statement regarding BASF's takeover interest, according to Evonik's investor relations page. Under EU market abuse rules, a listed German company issues an ad-hoc statement when it holds information likely to move its share price.
The statement itself signals that Evonik considered the approach price-relevant at the time.
Taken together, the two items leave a question open. BASF's quarter shows higher prices and earnings growth, and a bidder's financial capacity is one of the first things a target's shareholders will weigh. In my view, the thing to watch is whether BASF moves from a letter of interest to a formal offer document, and whether that document sets out consideration, conditions and timing. Until then the approach is an expression of intent, and the price effect for holders of either stock depends on what, if anything, is put to shareholders.
For ordinary savers, the BASF numbers are a reminder that a 14% sales rise can come mostly from pricing. For anyone following Evonik, the relevant date is not the letter but the first formal step beyond it. Neither event amounts to a completed transaction.


